GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ABCB · Dec 31, 2024

Ameris Bancorp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000351569-25-000006Bank
Sequential deposit growth10thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

-0.72% · CORE · VALID

Net-income growth65thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

33.29% · CORE · VALID

Interest-income growth35thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

7.64% · CORE · VALID

Cash and equivalents35thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$1.2B · CORE · VALID

Sequential loan growth5thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

-1.11% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History52 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
2.03%
Current
-0.72%
Delta
-2.75%
Earnings Growth Increased
Previous
23.84%
Current
33.29%
Delta
9.45%
Interest Income Growth Increased
Previous
7.44%
Current
7.64%
Delta
0.20%
Liquidity Decreased
Previous
$1.4B
Current
$1.2B
Delta
-$138.8M
Loan Growth Decreased
Previous
-0.13%
Current
-1.11%
Delta
-0.98%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.